MENU
+Compare
BEAM
Stock ticker: NASDAQ
AS OF
Jan 21, 04:59 PM (EDT)
Price
$24.53
Change
+$1.09 (+4.65%)
Capitalization
2.03B

BEAM Beam Therapeutics Forecast, Technical & Fundamental Analysis

a company, which develops and commercializes DNA base editing technologies for the treatment of human disease.

Industry Biotechnology
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for BEAM with price predictions
Jan 08, 2025

Momentum Indicator for BEAM turns negative, indicating new downward trend

BEAM saw its Momentum Indicator move below the 0 level on December 24, 2024. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 97 similar instances where the indicator turned negative. In of the 97 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for BEAM turned negative on December 27, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BEAM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 61 cases where BEAM's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

BEAM moved above its 50-day moving average on January 06, 2025 date and that indicates a change from a downward trend to an upward trend.

The 50-day moving average for BEAM moved above the 200-day moving average on December 27, 2024. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BEAM advanced for three days, in of 291 cases, the price rose further within the following month. The odds of a continued upward trend are .

BEAM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.453) is normal, around the industry mean (14.785). P/E Ratio (0.000) is within average values for comparable stocks, (88.252). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.844). BEAM has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (5.485) is also within normal values, averaging (264.102).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. BEAM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BEAM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

BEAM is expected to report earnings to rise 8.55% to -126 cents per share on March 04

Beam Therapeutics BEAM Stock Earnings Reports
Q4'24
Est.
$-1.27
Q3'24
Beat
by $0.01
Q2'24
Beat
by $0.02
Q1'24
Beat
by $0.20
Q4'23
Beat
by $2.42
The last earnings report on November 05 showed earnings per share of -116 cents, beating the estimate of -117 cents. With 802.56K shares outstanding, the current market capitalization sits at 2.03B.
A.I. Advisor
published General Information

General Information

a company, which develops and commercializes DNA base editing technologies for the treatment of human disease.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
238 Main Street
Phone
+1 857 327-8775
Employees
436
Web
https://www.beamtx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ALOAX18.640.19
+1.03%
Alger Mid Cap Focus A
GINDX28.700.28
+0.99%
Gotham Index Plus Institutional
PMBJX41.700.26
+0.63%
Principal MidCap J
THMEX14.390.09
+0.63%
CCT Thematic Equity Institutional
FSSRX21.800.11
+0.51%
Franklin Small Cap Growth R

BEAM and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
+0.17%
CRSP - BEAM
71%
Closely correlated
+0.57%
NTLA - BEAM
62%
Loosely correlated
+0.85%
DNLI - BEAM
60%
Loosely correlated
+1.20%
PRME - BEAM
60%
Loosely correlated
+0.70%
RXRX - BEAM
59%
Loosely correlated
+2.03%
More

Groups containing BEAM

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
+0.17%
BEAM
(2 stocks)
89%
Closely correlated
+3.48%